Merus N V (MRUS)

03:13 AM

Merus (NASDAQ:MRUS) Position Boosted by Wells Fargo & Company MN - Defense World

03:13 AM

May 13, 2025

Healthy Upside Potential: Merus N.V (MRUS) - Sete News

May 13, 2025

May 12, 2025

William Blair Weighs in on Merus’ Q2 Earnings (NASDAQ:MRUS) - Defense World

May 12, 2025

May 12, 2025

Leerink Partnrs Has Pessimistic Outlook of Merus Q2 Earnings - Defense World

May 12, 2025

May 12, 2025

HC Wainwright Has Pessimistic Outlook of Merus Q2 Earnings - Defense World

May 12, 2025

May 11, 2025

HC Wainwright Forecasts Merus’ FY2029 Earnings (NASDAQ:MRUS) - Defense World

May 11, 2025

May 11, 2025

Raymond James Financial Inc. Takes $347,000 Position in Merus (NASDAQ:MRUS) - Defense World

May 11, 2025

May 09, 2025

Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités - GlobeNewswire Inc.

May 09, 2025

May 09, 2025

Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025

May 09, 2025

Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités - GlobeNewswire

May 09, 2025

May 09, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 09, 2025

May 09, 2025

Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025

May 09, 2025

Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline - MSN

May 09, 2025

May 08, 2025

Wells Fargo Maintains Overweight Rating on MRUS but Lowers Price Target | MRUS Stock News - GuruFocus

May 08, 2025

May 08, 2025

Merus to Present at BofA Securities 2025 Health Care Conference - The Manila Times

May 08, 2025

May 08, 2025

Wells Fargo Adjusts Price Target for Merus (MRUS), Maintains Overweight Rating | MRUS Stock News - GuruFocus

May 08, 2025

May 07, 2025

Merus NV reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025

May 07, 2025

Earnings Flash (MRUS) Merus NV Posts Q1 Revenue $26.5M - marketscreener.com

May 07, 2025

May 07, 2025

Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update - The Manila Times

May 07, 2025

May 07, 2025

Financial Health Check: Examining Merus N.V (MRUS)’s Key Ratios - DWinneX

May 07, 2025

May 03, 2025

(MRUS) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 03, 2025

May 02, 2025

Was Merus N.V (MRUS)’s session last reading good? - uspostnews.com

May 02, 2025

May 02, 2025

Merus (NASDAQ:MRUS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

May 02, 2025

May 02, 2025

Q1 Earnings Forecast for Merus Issued By Leerink Partnrs - Defense World

May 02, 2025

May 02, 2025

Investor Network: Merus N.V. to Host Earnings Call - ACCESS Newswire

May 02, 2025

May 01, 2025

FY2027 Earnings Forecast for Merus Issued By Leerink Partnrs - Defense World

May 01, 2025

Apr 30, 2025

Merus (NASDAQ:MRUS) Position Lifted by Geode Capital Management LLC - Defense World

Apr 30, 2025

Apr 30, 2025

William Blair Reiterates Outperform Rating for Merus (NASDAQ:MRUS) - Defense World

Apr 30, 2025

Apr 29, 2025

Market Watch Highlights: Merus N.V (MRUS) Ends on an Upturn Note at 45.28 - DWinneX

Apr 29, 2025

Apr 26, 2025

Russell Investments Group Ltd. Decreases Stock Holdings in Merus (NASDAQ:MRUS) - Defense World

Apr 26, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

Merus N.V (MRUS) Is Worth Accumulating At Current Levels - Stocksregister

Apr 25, 2025

Apr 24, 2025

Daily Progress: Merus N.V (MRUS) Drop -3.19, Closing at 41.83 - DWinneX

Apr 24, 2025

Apr 24, 2025

MRUS Stock Sees Decline of Approximately -3.22% in Last Five Days - knoxdaily.com

Apr 24, 2025

Apr 24, 2025

Merus N.V’s Banking’s 100-Day Moving Average at 43.17: Will the Stock Break Through? - investchronicle.com

Apr 24, 2025

Apr 23, 2025

A stock that deserves closer examination: Merus N.V (MRUS) - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting - The Manila Times

Apr 23, 2025

Apr 23, 2025

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting | MRUS Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Merus N.V. Announces Interim Clinical Data for Petosemtamab with Pembrolizumab in PD-L1+ r/m HNSCC to be Presented at 2025 ASCO® Annual Meeting - Nasdaq

Apr 23, 2025

Apr 23, 2025

Breakthrough Cancer Drug Outperforms Standard Treatment: Phase 2 Trial Shows Superior Survival Rates - Stock Titan

Apr 23, 2025

Apr 22, 2025

ProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals | Libero Quotidiano.it - Libero Quotidiano

Apr 22, 2025

Apr 17, 2025

Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now? - Yahoo

Apr 17, 2025

Apr 17, 2025

10 Best High Short Interest Stocks to Buy Now - Insider Monkey

Apr 17, 2025

Apr 17, 2025

Merus N.V (NASDAQ: MRUS): Getting A Free Pass? - stocksregister.com

Apr 17, 2025

Apr 12, 2025

Merus’ (MRUS) “Buy” Rating Reiterated at Needham & Company LLC - Defense World

Apr 12, 2025

Apr 10, 2025

Raymond James Financial Inc. Invests $347,000 in Merus (NASDAQ:MRUS) - Defense World

Apr 10, 2025

Apr 07, 2025

Merus: Riding The Bispecific Wave In Oncology (NASDAQ:MRUS) - Seeking Alpha

Apr 07, 2025

Apr 05, 2025

KLP Kapitalforvaltning AS Purchases New Holdings in Merus (NASDAQ:MRUS) - Defense World

Apr 05, 2025

Apr 04, 2025

Merus stock touches 52-week low at $37.76 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Merus stock touches 52-week low at $37.76 amid market challenges - Investing.com Australia

Apr 04, 2025